Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1

Fig. 1

Downregulation of miR-361-5p in breast cancer and its association with poor prognosis. a ISH was used to compare the expression of miR-361-5p in BC tissues and corresponding normal tissues in a group of 60 patients. b Quantitative RT-PCR was used to detect the expression of miR-361-5p in BC tissues and corresponding normal tissues. c Relative expression of miR-361-5p was measured in BC tissues of different tumor stages by qRT-PCR. d Kaplan-Meier survival test was used to test the relationship between miR-361-5p expression and disease-free survival of BC patients. e The relative expression of miR-361-5p was detected in different BC cell lines by qRT-PCR. *P < 0.05, **P < 0.01

Back to article page